Wolters Kluwer today announced the nomination of Dr. Sophie Vandebroek for appointment to its Supervisory Board.
The nomination will be submitted to the Wolters Kluwer Annual General Meeting of Shareholders on April 23, 2020. Ms. Vandebroek will succeed Ms. Fidelma Russo who stepped down from the Supervisory Board at the end of 2019.
Ms. Vandebroek has held executive positions at IBM and Xerox as well as other technology-based organizations. Most recently, she was Chief Operating Officer at IBM Research and Vice President of Emerging Technology Partnerships for IBM Corporation. Prior to that, she served for over a decade as Chief Technology Officer of Xerox Corporation. She started her career as a Belgian National Science Foundation researcher at IMEC in Belgium.
Sophie Vandebroek is Board member of IDEXX Laboratories (U.S.), an S&P 500 biotechnology company, where she serves as member of the Finance and of the Nomination & Governance Committees. She held board memberships at Analogic Corp. a leader in healthcare and security technologies, PARC Inc., Nypro Corp., and was a member of the Technical Expert Council at Cummins Corp.
Ms. Vandebroek has been a member of the Advisory Council of the Dean of Engineering of the Massachusetts Institute of Technology (MIT) since 2010 and is currently the Inaugural School of Engineering Visiting Scholar at MIT. She is the holder of 14 US patent and is inducted in the Women in Technology International Hall of Fame. Ms. Vandebroek earned a Ph.D. Electrical Engineering from Cornell University (U.S.) and a master’s degree Magna Cum Laude in Electro-Mechanical Engineering from the KU Leuven University, Belgium.
Chairman of the Supervisory Board Frans Cremers commented: “We are very pleased to be able to nominate Sophie Vandebroek for appointment to our Supervisory Board. We look forward to benefitting from her extensive C-level experience with large technology companies. She will bring deep knowledge in the creation and application of technologies that drive growth.”
